| Shalee Buenemann, | |
|
1015 Bowles Ave, Fenton, MO 63026-2394 | |
| (636) 496-2000 | |
| Not Available |
| Full Name | Shalee Buenemann |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 1015 Bowles Ave, Fenton, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457134322 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 2019025504 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shalee Buenemann, 1587 Rathford Dr, Saint Louis, MO 63146-3908 Ph: (314) 277-6773 | Shalee Buenemann, 1015 Bowles Ave, Fenton, MO 63026-2394 Ph: (636) 496-2000 |
News Archive
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. TECNALIA designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Keryx Biopharmaceuticals Inc. reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade(R)) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.
Femasys Inc., an emerging medical device developer of women's healthcare solutions, announced today that it has received 510(k) clearance for the FemChec Pressure Management Device, the first device designed for a low pressure HSG as a confirmation test after a permanent sterilization procedure is performed.
Dental decay is one of the most common preventable health problems in children living in socially deprived areas of the UK.
A new international scheme providing lifesaving antimalarial drugs at cheap subsidised prices has rapidly transformed access to effective artemisinin combination therapies (ACTs) in seven African countries accounting for a quarter of the world's malaria cases, and could save millions of lives.
› Verified 1 days ago
Nicole Helsinger, PHARM.D Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 450 Old Smizer Mill Rd, Fenton, MO 63026 Phone: 636-349-2666 | |
Ms. Denise P Blackburn, APRN, FNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1011 Bowles Ave, Suite G10, Fenton, MO 63026 Phone: 314-965-9980 Fax: 314-965-1127 | |
Alison Jean Drerup, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 636-496-2000 | |
Laura Ann Rogers, CFNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1011 Bowles Ave, Ste 220, Fenton, MO 63026 Phone: 314-991-0137 | |
Michael Andrews, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1617 Manufacturers Dr, Fenton, MO 63026 Phone: 314-690-4500 | |
Natasha Marie Byrd, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1710 Fenpark Dr # 4, Fenton, MO 63026 Phone: 314-530-4700 Fax: 314-530-4711 | |
Timothy James Perkins, MSN, FNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 1270 Fenton Ridge Dr, Fenton, MO 63026 Phone: 314-620-5102 |